Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance

doi:10.3748/wjg.v13.i30.4072

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 30

This Article

(0)

(3767)

(3)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Viral Hepatitis

World J Gastroenterol. Aug 14, 2007; 13(30): 4072-4079
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4072

Full Size Figure Download Figure

Figure 3 Cumulative rates of sustained hepatitis B e antigen (HBeAg) seroconversion during one year of treatment with lamivudine (dashed line) and after switching to adefovir (continuous line). Only patients with positive HBeAg values at baseline were included in the analysis. Cumulative rates after one-year treatment of lamivudine and adefovir were 13% and 15%, respectively. LMV: lamivudine; ADV: adefovir dipivoxil; HBeAg: hepatitis B e antigen.

Citation: Seo YS, Kim JH, Yeon JE, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH. Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance. World J Gastroenterol 2007; 13(30): 4072-4079
URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4072.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i30.4072

Seo YS, Kim JH, Yeon JE, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH. Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance. World J Gastroenterol 2007; 13(30): 4072-4079 [PMID: 17696224 DOI: 10.3748/wjg.v13.i30.4072]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.